|
Volumn 120, Issue 1, 2009, Pages 10-13
|
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: Results from two placebo-controlled bipolar i maintenance studies
|
Author keywords
Bipolar; Depression; Lithium; Thyroid stimulating hormone
|
Indexed keywords
LAMOTRIGINE;
LITHIUM;
PLACEBO;
THYROTROPIN;
ARTICLE;
BIPOLAR I DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
THYROID FUNCTION;
TREATMENT OUTCOME;
ADULT;
AFFECT;
ANTICONVULSANTS;
ANTIMANIC AGENTS;
BIPOLAR DISORDER;
DOUBLE-BLIND METHOD;
HUMANS;
LITHIUM CARBONATE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
RETROSPECTIVE STUDIES;
THYROTROPIN;
TRIAZINES;
|
EID: 66749122990
PISSN: 0001690X
EISSN: 16000447
Source Type: Journal
DOI: 10.1111/j.1600-0447.2008.01343.x Document Type: Article |
Times cited : (37)
|
References (6)
|